date,title,source
Oct-17-18,"Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-22-18,Adaptimmune's stock tumbles after cancer study results prompts price target cut,MarketWatch
Oct-25-18,"Adaptimmune to Report Third Quarter 2018 Financial Results and Business Update on Tuesday, November 6, 2018",GlobeNewswire
Oct-25-18,3 Beaten-Down Biotech Stocks: Can They Bounce Back?,Motley Fool
Oct-25-18,Adaptimmune Therapeutics Worldwide Enters Oversold Territory,Zacks
Nov-06-18,Adaptimmune Reports Third Quarter 2018 Financial Results and Business Update,GlobeNewswire
Nov-07-18,Edited Transcript of ADAP earnings conference call or presentation 6-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-14-18,What You Must Know About Adaptimmune Therapeutics plcs (NASDAQ:ADAP) Financial Strength,Simply Wall St.
Nov-19-18,Edited Transcript of ADAP earnings conference call or presentation 6-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-20-18,Edited Transcript of ADAP earnings conference call or presentation 6-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-28-18,"Recent Analysis Shows Bellicum Pharmaceuticals, NetEase, Nice, Match Group, SpartanNash, and Adaptimmune Therapeutics Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Dec-12-18,Adaptimmune Announces that Gwen Binder will leave in January 2019,GlobeNewswire
Jan-02-19,What Percentage Of Adaptimmune Therapeutics plc (NASDAQ:ADAP) Shares Do Insiders Own?,Simply Wall St.
Jan-07-19,Dose Escalation in Liver Cancer Study with ADP-A2AFP (AFP) SPEAR T-cells and Moving to Expansion Phase in ADP-A2M10 (MAGE-A10) Lung Cancer Study after Favorable Safety Reviews,GlobeNewswire
Jan-08-19,"Radius Exceeds 2018 Financial Guidance, Provides Updates",Zacks
Jan-08-19,Alnylam (ALNY) Reports Preliminary Onpattro Revenues for Q4,Zacks
Jan-28-19,Adaptimmune Therapeutics PLC (ADAP) Upgraded to Buy: Here's What You Should Know,Zacks
Feb-07-19,Should You Worry About Adaptimmune Therapeutics plcs (NASDAQ:ADAP) CEO Salary Level?,Simply Wall St.
Feb-07-19,"Adaptimmune to Report Fourth Quarter / Full Year 2018 Financial Results and Business Update on Wednesday, February 27, 2019",GlobeNewswire
Feb-27-19,Edited Transcript of ADAP earnings conference call or presentation 27-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Feb-27-19,Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update,GlobeNewswire
Feb-28-19,Edited Transcript of ADAP earnings conference call or presentation 27-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Mar-01-19,Edited Transcript of ADAP earnings conference call or presentation 27-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Mar-05-19,Edited Transcript of ADAP earnings conference call or presentation 27-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Mar-06-19,Edited Transcript of ADAP earnings conference call or presentation 27-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Mar-15-19,Does Adaptimmune Therapeutics plc (NASDAQ:ADAP) Have A Particularly Volatile Share Price?,Simply Wall St.
Apr-01-19,Adaptimmune Presents Preclinical Data for its Next Generation SPEAR T-cell Targeting MAGE-A4 at the American Association for Cancer Research (AACR) Annual Meeting,GlobeNewswire
Apr-02-19,Adaptimmune Presents Safety Data with Evidence of Tumor Necrosis in One Patient from ADP-A2AFP Study at American Association for Cancer Research (AACR) Meeting,GlobeNewswire
Apr-12-19,These 3 Falling Knives Are Expected to Outperform,GuruFocus.com
